Immunocore Holdings plc Overview
Immunocore Holdings plc Target Price
Analysts' 12-month price predictions for IMCR.
Get informed when a big investor buys or sells
+ FollowShare Price
$32.5
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-19 | Mizuho Securities | $38 |  16.9% upside |  |
| 2026-01-07 | UBSMichael Yee | $55 | 69.2% upside | |
| 2025-11-10 | Morgan StanleySean Laaman | $36 | 10.8% upside | |
| 2025-10-31 | Wells FargoEva Fortea Verdejo | $60 | 84.6% upside | |
| 2025-03-07 | Morgan Stanley | $35 | 7.7% upside | |
| 2024-10-24 | UBSDavid Dai | $24 |  26.2% downside | |
| 2024-09-16 | OppenheimerJustin Kim | $89 | 173.8% upside | |
| 2024-09-12 | Mizuho SecuritiesGraig Suvannavejh | $72 | 121.5% upside | |
| 2024-08-28 | H.C. WainwrightPatrick Trucchio | $100 | 207.7% upside | |
| 2024-08-09 | BarclaysPeter Lawson | $66 | 103.1% upside | |
| 2024-05-13 | Mizuho SecuritiesGraig Suvannavejh | $88 | 170.8% upside | |
| 2024-05-09 | Canaccord GenuityBill Maughan | $67 | 106.2% upside | |
| 2022-12-15 | Goldman SachsRajan Sharma | $80 | 146.2% upside | |
| 2022-09-09 | JefferiesMichael Yee | $68 | 109.2% upside | |